Combination Study of LY188011 and Paclitaxel in Patients With Metastatic/Recurrent Breast Cancer After Neo-adjuvant/Adjuvant Chemotherapy With Anthracycline.
Phase of Trial: Phase II
Latest Information Update: 30 Mar 2010
At a glance
- Drugs Gemcitabine; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Dec 2009 Planned end date changed from Aug 2009 to Mar 2010 as reported by ClinicalTrials.gov.
- 20 Jan 2009 Status changed from completed to active, no longer recruiting; planned end date changed from 1 Feb 2008 to 1 Aug 2009, as reported by ClinicalTrials.gov.